DJP — Radioimmunoassay, Amphetamine Class II

FDA Device Classification

FDA product code DJP covers "Radioimmunoassay, Amphetamine", a Class II medical device regulated under 21 CFR 862.3100. Submissions are reviewed by the Clinical Toxicology panel. At least 9 recent 510(k) clearances have been granted under this product code.

Classification details

Product Code
DJP
Device Class
Class II
Regulation Number
862.3100
Submission Type
510(k)
Review Panel
TX
Medical Specialty
Clinical Toxicology
Implant
No

Recent 510(k) clearances

K-NumberApplicantDevice NameDate
K960526Diagnostic ReagentsPRIMIDONE EIA TESTMar 18, 1996
K913866Immunalysis CorporationURINE AMPHETAMINE DIRECT RIA KIT (I-125)Sep 25, 1991
K912755Roche Diagnostic SystemsABUSCREEN RADIOIMMUNOASSAY FOR AMPHETAMINEAug 26, 1991
K882228Diagnostic ProductsREVISED DOUBLE ANTIBODY AMPHETAMINEAug 8, 1988
K881817Roche Diagnostic SystemsABUSCREEN(R) ONTRAK(TM) FOR AMPHETAMINESJul 29, 1988
K854009Roche Diagnostic SystemsABUSCREEN RADIOIMMUNOASSAY FOR AMPHETAMINE-HIGH SPOct 15, 1985
K830482Hoffmann-La RocheABUSCREEN RADIOIMMUNOASSAY-AMPHETAMINEMar 24, 1983
K823212Hoffmann-La RocheABUSCREEN RADIOIMMUNOASSAY - AMPHETAMINENov 29, 1982
K812986Hoffmann-La RocheAGGLUTEX AMPHETAMINE TEST KITJan 22, 1982

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.